Publication | Open Access
Targeting transforming growth factor (TGF)‐βRI inhibits activation of β1 integrin and blocks vascular invasion in hepatocellular carcinoma†
138
Citations
42
References
2008
Year
TGF-beta1 promotes vascular invasion by activating beta1 integrin. This suggests a rationale for targeting TGF-betaRI in future clinical trials.
| Year | Citations | |
|---|---|---|
Page 1
Page 1